AstraZeneca hands over to Medicon Village

On 10 January, 2012, AstraZeneca will formally hand over its research facility in Lund to Medicon Village AB. The objective is to establish a new centre for research, innovation and entrepreneurship within Life Science. The deal involves premises with a total area available for letting of around 80,000 m2, of which laboratories account for about 30,000 m2.As part of its focused research strategy, AstraZeneca made the decision in March 2010 to move its research activities from Lund to Mölndal. The existing research facility is now being sold on to Medicon Village AB – a company that is owned